Abstract
Sixty-one gonococcal strains isolated in Greenland during 1998-1999 were tested
locally for susceptibility to penicillin and ciprofloxacin by a disc diffusion method
(Rosco®) and at the reference laboratory in Copenhagen by the agar
dilution method and the E-test®, showed that more than 60% of the strains
were less susceptible or resistant to penicillin (minimum inhibitory concentration
[MIC] ≥ 0.25 mg/L), indicating that penicillin should not be used as a first line
drug for the treatment of gonorrhoea in Greenland. The Rosco® disc
diffusion method only identified 8% of strains as less susceptible to penicillin.
Ciprofloxacin can still be used as a first line drug for treatment of gonorrhoea in
Greenland since decreased susceptibility was only seen in one imported strain.
However, the decreased susceptibility in this strain was not identified by the
Rosco® disc diffusion test, therefore the future local surveillance of
antibiotic resistance in
Get full access to this article
View all access options for this article.